Microbiology Quiz: Serology Antigen Antibody Tests
20 questions · exam conditions
0:00
Serology Antigen Antibody TestsQuestion 1 of 20

A sandwich immunoassay for a serum tumor marker yields an unexpectedly low result for a patient with a very high tumor burden confirmed by imaging. Suspecting an issue, the technician dilutes the serum 1:100 and re-runs the assay, which now produces an extremely high, off-scale result. What is the most likely cause of the initial falsely low reading?

A high-dose hook effect due to an excess of the tumor marker antigen.
A prozone effect due to an excess of patient antibodies against the tumor marker.
Interference from heterophile antibodies that was overcome by the dilution factor.
Limited stability of the tumor marker, which was preserved by the dilution buffer.
← Back to quizzes

Microbiology Quiz

Microbiology Quiz: Serology Antigen Antibody Tests

Practice Serology Antigen Antibody Tests in Microbiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Serology Antigen Antibody Tests, giving you a quick way to practice the rules, question types, and explanations that matter most for Microbiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A sandwich immunoassay for a serum tumor marker yields an unexpectedly low result for a patient with a very high tumor burden confirmed by imaging. Suspecting an issue, the technician dilutes the serum 1:100 and re-runs the assay, which now produces an extremely high, off-scale result. What is the most likely cause of the initial falsely low reading?

  1. A high-dose hook effect due to an excess of the tumor marker antigen. (correct answer)
  2. A prozone effect due to an excess of patient antibodies against the tumor marker.
  3. Interference from heterophile antibodies that was overcome by the dilution factor.
  4. Limited stability of the tumor marker, which was preserved by the dilution buffer.
Explanation: This is a classic example of the high-dose hook effect, a phenomenon that can occur in one-step sandwich immunoassays. When the antigen concentration is extremely high, it saturates both the solid-phase capture antibodies and the labeled detection antibodies simultaneously. This prevents the formation of the 'sandwich' (capture Ab-Ag-detection Ab), as few or no detection antibodies can bind to antigen that is already captured. The unbound detection antibodies are washed away, leading to a falsely low signal. Diluting the sample brings the antigen concentration back into the assay's working range, allowing the sandwich to form correctly and revealing the true high concentration.

Question 2

A patient undergoing a medical evaluation for an insurance policy has a positive Rapid Plasma Reagin (RPR) test. A confirmatory Fluorescent Treponemal Antibody Absorption (FTA-ABS) test is negative. The patient is asymptomatic and has a history of systemic lupus erythematosus (SLE). What is the most probable reason for these discrepant serology results?

  1. The patient is in the latent stage of syphilis, where non-treponemal tests are positive but treponemal tests can become negative.
  2. The FTA-ABS test is exhibiting a prozone phenomenon due to high antibody titers, leading to a false-negative result.
  3. The RPR test is a biological false positive due to anti-cardiolipin antibodies associated with the patient's SLE. (correct answer)
  4. The patient has a very early primary syphilis infection where the RPR is positive but the FTA-ABS has not yet become reactive.
Explanation: The RPR test is a non-treponemal test that detects antibodies to cardiolipin, a lipid released from damaged cells. While present in syphilis, anti-cardiolipin antibodies can also be produced in other conditions, notably autoimmune diseases like SLE, leading to a biological false positive. The FTA-ABS is a treponemal test that detects antibodies specific to Treponema pallidum antigens and is used for confirmation. A negative FTA-ABS with a positive RPR in a patient with SLE strongly suggests the RPR result is a false positive. Treponemal tests like FTA-ABS typically remain positive for life after infection, and they are usually the first to become positive in early infection.

Question 3

An Ouchterlony double immunodiffusion test is set up with three wells. The center well (As) contains polyclonal antiserum against human serum albumin (HSA) and human IgG. Well 1 contains purified HSA. Well 2 contains purified human IgG.

Based on the passage, what pattern of precipitin lines would be expected to form in the agar after incubation?

  1. A single, fused precipitin line forming an arc between wells 1 and 2, indicating identity.
  2. A single precipitin line between well As and well 1, and no line forming between well As and well 2.
  3. A precipitin line between wells As and 1 that forms a spur with the line between As and 2, indicating partial identity.
  4. Two separate precipitin lines that cross each other between the wells, indicating non-identity. (correct answer)
Explanation: When you encounter Ouchterlony double immunodiffusion questions, focus on understanding what happens when different antigens interact with polyclonal antisera containing multiple antibodies. In this setup, the center well contains polyclonal antiserum with antibodies against both HSA and human IgG - two completely different proteins. Well 1 has HSA, and well 2 has human IgG. Since these are distinct antigens with no shared epitopes, each will form independent precipitin lines with their respective antibodies from the center well. The correct pattern shows two separate precipitin lines that cross each other, demonstrating non-identity. One line forms between the center well and well 1 (HSA-anti-HSA complex), while another forms between the center well and well 2 (IgG-anti-IgG complex). These lines cross because they represent completely different antigen-antibody reactions with no immunological relationship. Choice A is wrong because a fused line indicates identity - meaning the same antigen in both outer wells, which isn't the case here. Choice B incorrectly suggests no reaction between the antiserum and IgG, but the polyclonal serum contains anti-IgG antibodies that will definitely react. Choice C describes partial identity with spur formation, which occurs when antigens share some but not all epitopes - again, not applicable since HSA and IgG are completely different proteins. Remember: crossing lines = non-identity (different antigens), fused lines = identity (same antigen), and spurred lines = partial identity (related antigens). The key is recognizing what antigens you're comparing.

Question 4

An enzyme immunoassay (EIA) result is reported as an index value, calculated by dividing the patient sample's optical density (OD) by the OD of the kit's cut-off calibrator. An index value greater than 1.0 is considered reactive. A patient's sample has an OD of 0.960. The cut-off calibrator OD for the run is 0.240. The negative control OD is 0.080. How should this result be interpreted?

  1. Negative, because the patient OD of 0.960 is less than 1.0.
  2. Invalid, because the negative control OD was not used in the index calculation.
  3. Equivocal, because the patient OD is close to the 1.0 threshold.
  4. Positive, with an index value of 4.0. (correct answer)
Explanation: When you encounter EIA index value calculations, remember that the index is simply the patient's optical density divided by the cut-off calibrator's optical density. This standardizes results across different test runs. Let's calculate the index value: Patient ODCut-off Calibrator OD=0.9600.240=4.0\frac{\text{Patient OD}}{\text{Cut-off Calibrator OD}} = \frac{0.960}{0.240} = 4.0 Since the index value of 4.0 is greater than 1.0, this result is positive (reactive). The answer is D. Now let's examine why the other options are incorrect: Option A misunderstands what gets compared to 1.0. You don't compare the raw patient OD (0.960) to 1.0; you compare the calculated index value (4.0) to 1.0. This is a common trap that catches students who skip the calculation step. Option B incorrectly suggests the negative control should be used in the index calculation. The negative control (0.080) serves as a quality control measure to ensure the assay is working properly, but it's not part of the index formula. Only the patient OD and cut-off calibrator OD are used. Option C calls this "equivocal," but an index of 4.0 is definitively positive—it's four times above the threshold, not borderline at all. This option might tempt students who focused on the patient's raw OD being below 1.0 instead of calculating the actual index. Always perform the mathematical calculation first in EIA problems. The index value, not the raw optical density, determines the final interpretation.

Question 5

A patient's serum gives a false-positive result in a sandwich ELISA for a viral antigen. The patient has no symptoms or other evidence of infection. Further investigation reveals the presence of human anti-mouse antibodies (HAMA) in the patient's serum from a previous monoclonal antibody therapy. How do HAMA typically cause this type of interference?

  1. By binding to the blocking agent on the plate, preventing the sample from entering the well.
  2. By cross-linking the murine-derived capture and detection antibodies in the absence of antigen. (correct answer)
  3. By degrading the viral antigen in the patient's serum before it can be detected by the assay.
  4. By competitively inhibiting the binding of the detection antibody to the antigen-capture antibody complex.
Explanation: Human anti-mouse antibodies (HAMA) are a type of heterophile antibody that can interfere with two-site sandwich immunoassays that use mouse monoclonal antibodies. HAMA can simultaneously bind to the Fc portion of the mouse capture antibody on the solid phase and the Fc portion of the mouse detection antibody. This cross-linking action forms a complete 'sandwich' and generates a signal even when no antigen is present, leading to a false-positive result.

Question 6

A laboratory utilizes a latex agglutination test to detect Clostridium difficile toxin in stool samples. The latex particles provided in the kit are coated with anti-toxin antibodies. A positive stool sample is mixed with the reagent. Which term best describes this type of assay and the expected positive result?

  1. Passive agglutination; clearing of the suspension.
  2. Direct agglutination; visible clumping of the C. difficile bacteria.
  3. Agglutination inhibition; formation of a button of unclumped particles.
  4. Reverse passive agglutination; visible clumping of the latex particles. (correct answer)
Explanation: When you encounter questions about agglutination tests, focus on understanding what's being coated with antibodies and what's being detected. This determines both the assay type and the expected result. In this C. difficile toxin detection test, latex particles are pre-coated with anti-toxin antibodies. When toxin is present in the stool sample, it binds to these antibodies on the latex particles, causing the particles to clump together visibly. This is called "reverse passive agglutination" because the antibodies (not antigens) are attached to the carrier particles, and the target antigen (toxin) is in the test sample. The positive result is visible clumping of the latex particles. Answer choice A is incorrect because "passive agglutination" typically refers to antigens coated on particles, not antibodies. Also, clearing would indicate a negative result, not positive clumping. Choice B is wrong because this isn't direct agglutination of bacteria—you're detecting soluble toxin, not whole bacterial cells. Choice C misidentifies the assay type; agglutination inhibition would require a different setup where agglutination is prevented rather than promoted. Remember this pattern: In latex agglutination tests for toxin detection, if antibodies are coated on the particles and you're looking for antigen in the sample, it's reverse passive agglutination. A positive result always means visible clumping occurs because the target molecule successfully bridges the coated particles together.

Question 7

A tube agglutination test for Brucella abortus antibodies is performed on a patient's serum. Serial dilutions of the serum are tested against a constant amount of Brucella antigen. Following incubation, strong agglutination is observed in tubes with high serum dilutions (e.g., 1:160, 1:320), but no agglutination is seen in tubes with low serum dilutions (e.g., 1:10, 1:20). What is the most likely explanation for this pattern?

  1. The postzone phenomenon, where an excess of antigen prevents effective cross-linking of antibodies.
  2. The prozone phenomenon, where an excess of antibody saturates antigen sites and prevents lattice formation. (correct answer)
  3. The presence of low-avidity antibodies that only bind effectively when concentrated at low dilutions.
  4. Competitive inhibition by a structurally similar, non-agglutinating antibody isotype in the patient's serum.
Explanation: The prozone phenomenon occurs when the concentration of antibodies is so high that each antigen particle is saturated with individual antibodies, preventing the formation of the antibody-antigen lattice required for visible agglutination. Diluting the serum reduces the antibody concentration to a more optimal ratio with the antigen, allowing agglutination to occur. The postzone phenomenon is caused by antigen excess, which would not be the case here as the antigen amount is constant. Low-avidity antibodies would likely produce weak or no agglutination at all dilutions. While blocking antibodies exist, the classic textbook cause for this specific pattern is prozone.

Question 8

A physician suspects a patient has a primary infection with Epstein-Barr virus (EBV). An acute serum sample, taken 5 days after symptom onset, shows an IgG titer of 1:20. A second, convalescent serum sample is collected 3 weeks later and tested in parallel. Which convalescent titer result would be most indicative of a current, primary EBV infection?

  1. 1:20
  2. 1:40
  3. 1:80 (correct answer)
  4. Negative
Explanation: A diagnosis of a current or recent primary infection is typically confirmed by seroconversion (going from negative to positive) or by demonstrating a significant rise in antibody titer between acute and convalescent phase sera. A four-fold or greater increase in titer is generally considered diagnostically significant. A rise from 1:20 to 1:80 represents a four-fold increase (80/20 = 4) and strongly indicates a primary infection. A titer of 1:40 is only a two-fold rise, which is not typically considered significant. A stable titer of 1:20 or a negative result would not support a diagnosis of a current primary infection.

Question 9

A lab wants to confirm the identity of a bacterial isolate using a serological method. They have polyclonal antiserum raised against the whole, heat-killed bacterium. They also have a monoclonal antibody that recognizes a single, highly specific surface epitope. Which reagent would provide a more specific identification and which would be more likely to show cross-reactivity with closely related species?

  1. More specific: monoclonal. More cross-reactive: polyclonal. (correct answer)
  2. More specific: polyclonal. More cross-reactive: monoclonal.
  3. Both would have equal specificity as they were raised against the same bacterium.
  4. Specificity cannot be determined without knowing the antibody titers for each reagent.
Explanation: A monoclonal antibody (mAb) is, by definition, specific for a single epitope. This high specificity makes it an excellent tool for precise identification and minimizes the chance of binding to other organisms. A polyclonal antiserum contains a mixture of antibodies that recognize many different epitopes on the target bacterium. Because closely related bacterial species often share some common or structurally similar epitopes, the polyclonal antiserum is much more likely to cross-react with these other species. Therefore, the monoclonal antibody provides higher specificity, while the polyclonal antiserum is more prone to cross-reactivity.

Question 10

A patient's serum is screened for HIV using an ELISA and is found to be reactive. A confirmatory Western blot is performed, which shows a distinct band for the p24 antigen but no bands for gp41 or gp120/160. According to CDC guidelines, what is the correct interpretation of this result and the recommended course of action?

  1. Positive for HIV; the presence of any specific viral band, such as p24, is sufficient for diagnosis.
  2. Negative for HIV; the reactive ELISA was a false positive as confirmatory criteria were not met.
  3. Indeterminate; the patient should be re-tested in 2-4 weeks to assess for seroconversion. (correct answer)
  4. Technical error; the Western blot assay should be repeated immediately using the same patient sample.
Explanation: According to CDC criteria, a Western blot is considered positive for HIV-1 if at least two of the following three bands are present: p24, gp41, and gp120/160. The presence of only one band (in this case, p24) makes the result indeterminate. This pattern can occur in very early infection before the full antibody response has developed. Therefore, the standard recommendation is to collect a new sample in 2-4 weeks to check for the appearance of additional bands (seroconversion). It is not considered a negative result, nor is it sufficient for a positive diagnosis.

Question 11

A physician suspects a patient has a primary infection with Epstein-Barr virus (EBV). An acute serum sample, taken 5 days after symptom onset, shows an IgG titer of 1:20. A second, convalescent serum sample is collected 3 weeks later and tested in parallel. Which convalescent titer result would be most indicative of a current, primary EBV infection?

  1. 1:20
  2. 1:40
  3. 1:80 (correct answer)
  4. Negative
Explanation: A diagnosis of a current or recent primary infection is typically confirmed by seroconversion (going from negative to positive) or by demonstrating a significant rise in antibody titer between acute and convalescent phase sera. A four-fold or greater increase in titer is generally considered diagnostically significant. A rise from 1:20 to 1:80 represents a four-fold increase (80/20 = 4) and strongly indicates a primary infection. A titer of 1:40 is only a two-fold rise, which is not typically considered significant. A stable titer of 1:20 or a negative result would not support a diagnosis of a current primary infection.

Question 12

A tube agglutination test for Brucella abortus antibodies is performed on a patient's serum. Serial dilutions of the serum are tested against a constant amount of Brucella antigen. Following incubation, strong agglutination is observed in tubes with high serum dilutions (e.g., 1:160, 1:320), but no agglutination is seen in tubes with low serum dilutions (e.g., 1:10, 1:20). What is the most likely explanation for this pattern?

  1. The postzone phenomenon, where an excess of antigen prevents effective cross-linking of antibodies.
  2. The prozone phenomenon, where an excess of antibody saturates antigen sites and prevents lattice formation. (correct answer)
  3. The presence of low-avidity antibodies that only bind effectively when concentrated at low dilutions.
  4. Competitive inhibition by a structurally similar, non-agglutinating antibody isotype in the patient's serum.
Explanation: The prozone phenomenon occurs when the concentration of antibodies is so high that each antigen particle is saturated with individual antibodies, preventing the formation of the antibody-antigen lattice required for visible agglutination. Diluting the serum reduces the antibody concentration to a more optimal ratio with the antigen, allowing agglutination to occur. The postzone phenomenon is caused by antigen excess, which would not be the case here as the antigen amount is constant. Low-avidity antibodies would likely produce weak or no agglutination at all dilutions. While blocking antibodies exist, the classic textbook cause for this specific pattern is prozone.

Question 13

A laboratory is developing an immunofluorescence assay to detect a viral antigen in tissue sections. They can use a direct method with a single fluorescently-labeled primary antibody or an indirect method with an unlabeled primary antibody followed by a fluorescently-labeled secondary antibody. To achieve the highest possible sensitivity for detecting low amounts of antigen, which method is preferable and why?

  1. Direct, because it involves fewer incubation and wash steps, minimizing the loss of antigen from the tissue.
  2. Indirect, because multiple fluorescent secondary antibodies can bind to a single primary antibody, amplifying the signal. (correct answer)
  3. Direct, because the primary antibody has a higher affinity for the antigen than the secondary antibody does.
  4. Indirect, because the secondary antibody provides a universal reagent that can be used for multiple primary antibodies.
Explanation: The indirect immunofluorescence method offers higher sensitivity due to signal amplification. Each primary antibody that binds to the target antigen can be bound by multiple fluorescently-labeled secondary antibodies. This multiplication effect results in a much brighter signal than the direct method, where only one fluorescent label is attached to each bound primary antibody. While the indirect method does have more steps and the secondary antibody is a versatile reagent, its primary advantage for sensitivity is signal amplification.

Question 14

A competitive ELISA is used to measure the concentration of a specific hormone in patient serum. In this assay format, microtiter wells are coated with the hormone. Patient serum is incubated in the wells along with a fixed amount of enzyme-labeled anti-hormone antibody. After washing, a colorimetric substrate is added. A patient with a very high level of the hormone is tested. What result is expected?

  1. A high optical density, because more patient hormone binds to the labeled antibody, capturing more enzyme in the well.
  2. A low optical density, because the patient's hormone competes with the coated hormone for binding to the labeled antibody. (correct answer)
  3. An optical density similar to the negative control, as the excess hormone will cause a hook effect.
  4. A variable optical density that cannot be interpreted without also performing a sandwich ELISA on the sample.
Explanation: In a competitive ELISA for antigen detection, the signal is inversely proportional to the amount of antigen in the sample. The hormone in the patient's sample (free antigen) competes with the hormone coated on the plate for binding to a limited number of enzyme-labeled antibodies. If the patient has a high hormone level, most of the labeled antibodies will bind to the patient's hormone in the solution phase and be washed away. Fewer labeled antibodies will bind to the hormone on the plate, resulting in a low signal (low optical density).

Question 15

A new rapid antigen detection test for a respiratory virus is evaluated against the gold standard PCR. Among 300 patients with the infection confirmed by PCR, the new test is positive for 240. Among 700 patients without the infection, the new test is negative for 630. What are the sensitivity and specificity of this new rapid test?

  1. Sensitivity is 80% and specificity is 90%. (correct answer)
  2. Sensitivity is 90% and specificity is 80%.
  3. Sensitivity is 77% and specificity is 93%.
  4. Sensitivity is 240/1000 and specificity is 630/1000.
Explanation: Sensitivity is the ability of a test to correctly identify those with the disease (True Positives / (True Positives + False Negatives)). Here, TP = 240 and FN = 300 - 240 = 60. So, Sensitivity = 240 / (240 + 60) = 240 / 300 = 0.80 or 80%. Specificity is the ability of a test to correctly identify those without the disease (True Negatives / (True Negatives + False Positives)). Here, TN = 630 and FP = 700 - 630 = 70. So, Specificity = 630 / (630 + 70) = 630 / 700 = 0.90 or 90%.

Question 16

A patient undergoing a medical evaluation for an insurance policy has a positive Rapid Plasma Reagin (RPR) test. A confirmatory Fluorescent Treponemal Antibody Absorption (FTA-ABS) test is negative. The patient is asymptomatic and has a history of systemic lupus erythematosus (SLE). What is the most probable reason for these discrepant serology results?

  1. The patient is in the latent stage of syphilis, where non-treponemal tests are positive but treponemal tests can become negative.
  2. The FTA-ABS test is exhibiting a prozone phenomenon due to high antibody titers, leading to a false-negative result.
  3. The RPR test is a biological false positive due to anti-cardiolipin antibodies associated with the patient's SLE. (correct answer)
  4. The patient has a very early primary syphilis infection where the RPR is positive but the FTA-ABS has not yet become reactive.
Explanation: The RPR test is a non-treponemal test that detects antibodies to cardiolipin, a lipid released from damaged cells. While present in syphilis, anti-cardiolipin antibodies can also be produced in other conditions, notably autoimmune diseases like SLE, leading to a biological false positive. The FTA-ABS is a treponemal test that detects antibodies specific to Treponema pallidum antigens and is used for confirmation. A negative FTA-ABS with a positive RPR in a patient with SLE strongly suggests the RPR result is a false positive. Treponemal tests like FTA-ABS typically remain positive for life after infection, and they are usually the first to become positive in early infection.

Question 17

A patient's serum gives a false-positive result in a sandwich ELISA for a viral antigen. The patient has no symptoms or other evidence of infection. Further investigation reveals the presence of human anti-mouse antibodies (HAMA) in the patient's serum from a previous monoclonal antibody therapy. How do HAMA typically cause this type of interference?

  1. By binding to the blocking agent on the plate, preventing the sample from entering the well.
  2. By cross-linking the murine-derived capture and detection antibodies in the absence of antigen. (correct answer)
  3. By degrading the viral antigen in the patient's serum before it can be detected by the assay.
  4. By competitively inhibiting the binding of the detection antibody to the antigen-capture antibody complex.
Explanation: Human anti-mouse antibodies (HAMA) are a type of heterophile antibody that can interfere with two-site sandwich immunoassays that use mouse monoclonal antibodies. HAMA can simultaneously bind to the Fc portion of the mouse capture antibody on the solid phase and the Fc portion of the mouse detection antibody. This cross-linking action forms a complete 'sandwich' and generates a signal even when no antigen is present, leading to a false-positive result.

Question 18

In a single radial immunodiffusion (Mancini) assay, the antigen concentration is proportional to the square of the precipitin ring diameter. Standards containing 50 U/mL and 200 U/mL of an antigen produce rings with diameters of 10 mm and 20 mm, respectively. A patient sample tested in the same assay produces a ring with a 15 mm diameter. What is the antigen concentration in the patient's sample?

  1. 100.0 U/mL
  2. 112.5 U/mL (correct answer)
  3. 125.0 U/mL
  4. 150.0 U/mL
Explanation: The relationship is C = k * d², where C is concentration, d is diameter, and k is a constant. First, find k using a standard. Using the first standard: 50 = k * (10)² = 100k, so k = 0.5. (Check with the second standard: 200 = 0.5 * (20)² = 0.5 * 400 = 200. The constant holds). Now, use k to find the patient's concentration: C = 0.5 * (15)² = 0.5 * 225 = 112.5 U/mL. The common mistake is to assume a linear relationship between concentration and diameter (not diameter squared), which would lead to the incorrect answer of 125 U/mL (since 15 mm is halfway between 10 mm and 20 mm, the concentration would be assumed to be halfway between 50 and 200).

Question 19

A hemagglutination inhibition test is performed on a patient's serum to detect antibodies against influenza virus. A standardized amount of virus is mixed with serial dilutions of the patient's serum, and then a suspension of chicken red blood cells (RBCs) is added. A positive result, indicating the presence of anti-influenza antibodies, would be visualized as:

  1. A diffuse lattice of agglutinated RBCs covering the bottom of the microtiter well.
  2. A precipitin ring forming at the interface between the serum and RBC layers.
  3. Visible hemolysis of the RBCs, resulting in a clear, red-tinged supernatant.
  4. A compact button of non-agglutinated RBCs that have settled at the bottom of the well. (correct answer)
Explanation: When you encounter hemagglutination inhibition (HI) tests, remember that you're looking at a two-step process where antibodies can block viral binding to red blood cells. Influenza viruses naturally agglutinate (clump) chicken RBCs because viral hemagglutinin proteins bind to sialic acid receptors on the RBC surface. The correct answer is D because when anti-influenza antibodies are present in the patient's serum, they bind to the viral hemagglutinin proteins and prevent the virus from attaching to the RBCs. Without viral binding, the RBCs cannot form clumps and instead settle as a compact button at the bottom of the well. This inhibition of hemagglutination indicates a positive result for antibodies. Option A describes what happens in a negative result—when no antibodies are present, the virus freely agglutinates the RBCs, creating a diffuse lattice pattern across the well bottom. Option B incorrectly describes a precipitin reaction, which involves antigen-antibody complexes forming visible precipitates, not the mechanism of HI testing. Option C describes hemolysis (RBC destruction), which isn't part of hemagglutination testing and would indicate cellular damage rather than antibody presence. The key study tip: In HI tests, counterintuitively, inhibition (no clumping) equals a positive antibody result, while agglutination indicates no protective antibodies. Think "antibodies block viral attachment = compact button = positive for immunity." This pattern appears frequently in virology questions about serological testing.

Question 20

An indirect immunofluorescence assay (IFA) is performed to detect antibodies against a specific bacterium. A technician performing the assay forgets to add the blocking agent (e.g., bovine serum albumin) after fixing the bacteria to the slide. How would this omission most likely affect the test result?

  1. It would cause a false-negative result due to the primary antibody being unable to bind to the antigen.
  2. It would have no effect on the result, as the blocking agent only affects antigen stability.
  3. It would cause a false-positive or high background signal due to non-specific binding of antibodies. (correct answer)
  4. It would prevent the fluorescent conjugate from binding to the primary antibody, leading to no signal.
Explanation: The blocking agent is a crucial reagent used to cover non-specific binding sites on the solid phase (the glass slide). By omitting the blocking step, these sites remain exposed. Consequently, both the primary and/or the secondary antibodies can bind non-specifically to the slide surface, not just to the target antigen. This results in a high background fluorescence or a false-positive signal, making the test uninterpretable. The omission would not prevent specific binding, but it would add significant non-specific binding.